Use of short-term drug testing as part of a systematic approach for evaluation of antiarrhythmic drugs.
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D004341:Drug Evaluation / Q000379:methods; D004558:Electric Stimulation; D006801:Humans; D008991:Monitoring, Physiologic; D011342:Procainamide / Q000627:therapeutic use; D011379:Prognosis; D011405:Propafenone; D011427:Propiophenones / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D011427:Propiophenones; D011405:Propafenone; D011802:Quinidine; D011342:Procainamide